Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE)

What is the purpose of this trial?

PRESERVE is a multi-center, prospective, open-label, non-randomized investigation of commercially available IVC filters from 7 manufacturers placed in subjects for the prevention of pulmonary embolism (PE). This study will enroll approximately 2,100 IVC filter subjects at up to 60 sites in the US. All treated subjects will be evaluated at procedure, 3-months, 6-months (phone), 12-months, 18-months (phone), and 24-months post-procedure. The primary objective of this investigational device exemption (IDE) clinical investigation is to evaluate the safety and effectiveness of the commercially available IVC filters (retrievable and permanent) in subjects with clinical need for mechanical prophylaxis of PE with an IVC filter.


Participation Guidelines

Ages: 18 years and older

Gender: Both


New England Research Institute

Dates: 03/23/2016 - 05/01/2018

Last Updated: 03/24/2016

Study HIC#: 1508016319

Get Involved

For more information about this study, contact:
Jacqueline Marie Gamberdella
+1 203-737-1899
jacqueline.gamberdella@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image